Labelling Solutions
From labelling to lifelines: How connected networks are redefining patient safety
precision is critical. For life sciences organisations, that uncertainty is not just operational; it is a direct patient safety concern.
By Laura Johnson, senior sales director, life sciences at Loftware
I
n life sciences, patient safety is often framed around clinical innovation or regulatory compliance. Yet one of the most critical safeguards sits much closer to the product itself:
the label.
A labelling error is never just an operational oversight. A missing data point, outdated instructions for use or a misidentifi ed product can trigger a chain reaction of risks - from product mix-ups and delayed treatment to regulatory non-conformance and recalls. In the most serious cases, these failures directly compromise patient safety and erode public trust. As global supply chains grow more distributed and regulatory pressures intensify, the margin for error is disappearing. Life sciences organisations can no longer aff ord to treat labelling as a downstream, administrative function. It must be recognised as a strategic control point - one that underpins safety, compliance and continuity of care.
WHY DISCONNECTED SYSTEMS CREATE UNNECESSARY RISK
However, there is a fundamental disconnect at the heart of many operations. While regulators defi ne what information must appear on a label, the infrastructure required to ensure that information is accurate, current and consistently applied across every partner and location is often fragmented. Product identifi cation is still too frequently managed within siloed systems, disconnected from the broader network of suppliers, contract manufacturers and distribution partners responsible for bringing products to market.
In an era where supply chains are only as strong as their weakest link, this fragmentation creates risk. A single breakdown in product identifi cation - whether through misalignment between partners, outdated data or manual processes - can halt production lines, delay shipments, trigger recalls and introduce uncertainty into environments where
THE SHIFT TO CONNECTED PRODUCT IDENTIFICATION NETWORKS
This is why the industry is undergoing a fundamental shift: from isolated labelling systems to connected product identifi cation networks.
These emerging ecosystems move beyond the traditional boundaries of enterprise systems, creating structured digital connections between organisations and their trading partners. By establishing a unifi ed, governed framework for how product identifi cation data is created, shared and applied, they replace fragmented coordination with a single, trusted foundation.
At the core of this approach is the concept of a “single source of truth” - not just within an organisation, but across its entire supply network. Patient safety is ultimately a systems issue. The accuracy of a label depends on every upstream process working in alignment, from regulatory updates and artwork management to packaging execution and supplier collaboration. When each stakeholder operates from a diff erent version of information, the risk multiplies.
FASTER, SMARTER RECALL READINESS This approach also has profound implications for recall readiness. In life sciences, recalls demand speed, precision and absolute confi dence. Yet without end-to-end visibility, identifying aff ected products and coordinating corrective action can be slow and disruptive. With connected identifi cation
networks, organisations gain the ability to trace products across their lifecycle in real time, pinpoint impacted batches instantly and deploy updates across their partner ecosystem without delay. This not only reduces risk exposure but ensures that action can be taken decisively to protect patients while minimising unnecessary disruption to supply.
FIGHTING COUNTERFEITING THROUGH AUTHENTICITY VERIFICATION
The same infrastructure is increasingly critical in the fi ght against counterfeiting.
Illegitimate or diverted products pose a growing threat to both patient safety and brand integrity. By securely linking product identity to verifi able digital records, connected systems enable stakeholders to confi rm origin, compliance status and lifecycle data instantly. This creates a stronger foundation of trust - one where authenticity can be validated at every stage of the supply chain.
SMART PACKAGING AS AN ALWAYS-ON ENGAGEMENT CHANNEL
Packaging is becoming an “always-on” channel for engagement - connecting organisations directly with patients and healthcare providers. Intelligent, connected packaging can deliver real-time updates, usage guidance and personalised information, extending support far beyond the point of manufacture. In doing so, it reinforces transparency, improves adherence and strengthens trust in both product and brand.
FROM OPERATIONAL PROCESS TO PATIENT LIFELINE
Ultimately, what we are seeing is a redefi nition of product identifi cation itself. No longer confi ned to labels or individual systems, it is becoming a dynamic, network-driven capability that connects systems, partners and processes in real time. It provides the visibility, governance and agility required to operate in an increasingly complex and unpredictable environment.
For life sciences organisations, the implications are clear. Patient safety cannot rely on fragmented infrastructure or manual safeguards. It must be built on connected, collaborative networks that ensure accuracy at every point of the supply chain.
Labels are not just labels. They are lifelines - carrying the information that patients, providers, and regulators depend on to make safe decisions.
www.convertermag.com
July/August 2026
23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38
